These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27080830)

  • 1. The history of pharmacovigilance.
    Caron J; Rochoy M; Gaboriau L; Gautier S
    Therapie; 2016 Apr; 71(2):129-34. PubMed ID: 27080830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An historical overview over Pharmacovigilance.
    Fornasier G; Francescon S; Leone R; Baldo P
    Int J Clin Pharm; 2018 Aug; 40(4):744-747. PubMed ID: 29948743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical Perspective of Nephrotoxicity.
    Rankin GO; Valentovic MA
    Toxicol Sci; 2018 Aug; 164(2):377-378. PubMed ID: 30053230
    [No Abstract]   [Full Text] [Related]  

  • 4. A plea for a more epidemiological and patient-oriented pharmacovigilance.
    Scurti V; Romero M; Tognoni G
    Eur J Clin Pharmacol; 2012 Jan; 68(1):11-9. PubMed ID: 21773732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 150 years of pharmacovigilance.
    Routledge P
    Lancet; 1998 Apr; 351(9110):1200-1. PubMed ID: 9643710
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of pharmacovigilance: a personal view.
    Edwards IR
    Eur J Clin Pharmacol; 2008 Feb; 64(2):173-81. PubMed ID: 18172624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Historical consideration of the outbreaks induced by adverse drug reactions in Japan and the necessary preventive schemes depending on the accurate use of drug informatics].
    Yamazaki M
    Yakushigaku Zasshi; 2011; 46(2):78-82. PubMed ID: 22849238
    [No Abstract]   [Full Text] [Related]  

  • 8. Seeking medicine for the soul.
    Aronson SM
    R I Med J (2013); 2013 Jul; 96(7):11-2. PubMed ID: 23819133
    [No Abstract]   [Full Text] [Related]  

  • 9. [The history of adverse drug reactions, relief for these health damage and safety measures in Japan].
    Takahashi H
    Yakushigaku Zasshi; 2009; 44(2):64-70. PubMed ID: 20527311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harvey Washington Wiley (1844-1930): champion of the Pure Food and Drugs Act.
    Wong V; Tan SY
    Singapore Med J; 2009 Mar; 50(3):235-6. PubMed ID: 19352563
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacovigilance in resource-limited countries.
    Olsson S; Pal SN; Dodoo A
    Expert Rev Clin Pharmacol; 2015; 8(4):449-60. PubMed ID: 26041035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance implemented by patients: A necessity in the 21st century.
    Lafond J
    Therapie; 2016 Apr; 71(2):245-7. PubMed ID: 27080846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reading our lips: the history of lipstick regulation in Western seats of power.
    Schaffer SE
    Food Drug Law J; 2007; 62(1):165-225. PubMed ID: 17444030
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
    Dudzinski DM
    Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulating Homeopathic Products - A Century of Dilute Interest.
    Podolsky SH; Kesselheim AS
    N Engl J Med; 2016 Jan; 374(3):201-3. PubMed ID: 26789866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food and Drug Administration: 100 years of protection.
    Mosocco DJ
    Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric regulatory initiatives.
    Hirschfeld S; Saint-Raymond A
    Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA.
    Scheindlin S
    Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Drugs for Use in Infants and Children: Where Are We Now, and Where Must We Go?
    Brown RE
    Anesth Analg; 2019 Oct; 129(4):1170-1174. PubMed ID: 30882517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.